JP2006521334A5 - - Google Patents

Download PDF

Info

Publication number
JP2006521334A5
JP2006521334A5 JP2006505750A JP2006505750A JP2006521334A5 JP 2006521334 A5 JP2006521334 A5 JP 2006521334A5 JP 2006505750 A JP2006505750 A JP 2006505750A JP 2006505750 A JP2006505750 A JP 2006505750A JP 2006521334 A5 JP2006521334 A5 JP 2006521334A5
Authority
JP
Japan
Prior art keywords
wax
lipid
solid particles
solid
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006505750A
Other languages
English (en)
Japanese (ja)
Other versions
JP5072355B2 (ja
JP2006521334A (ja
Filing date
Publication date
Priority claimed from FR0303568A external-priority patent/FR2852843B1/fr
Application filed filed Critical
Publication of JP2006521334A publication Critical patent/JP2006521334A/ja
Publication of JP2006521334A5 publication Critical patent/JP2006521334A5/ja
Application granted granted Critical
Publication of JP5072355B2 publication Critical patent/JP5072355B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006505750A 2003-03-24 2004-03-24 有効成分輸送のための新規なガレヌス製剤系、調製方法及び使用 Expired - Fee Related JP5072355B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR03/03568 2003-03-24
FR0303568A FR2852843B1 (fr) 2003-03-24 2003-03-24 Systeme galenique permettant le masquage du gout
PCT/FR2004/000729 WO2004084856A2 (fr) 2003-03-24 2004-03-24 Nouveau systeme galenique pour le transport d’actif, procede de preparation et utilisation

Publications (3)

Publication Number Publication Date
JP2006521334A JP2006521334A (ja) 2006-09-21
JP2006521334A5 true JP2006521334A5 (enExample) 2011-03-31
JP5072355B2 JP5072355B2 (ja) 2012-11-14

Family

ID=32947122

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006505750A Expired - Fee Related JP5072355B2 (ja) 2003-03-24 2004-03-24 有効成分輸送のための新規なガレヌス製剤系、調製方法及び使用

Country Status (10)

Country Link
US (3) US20070116728A1 (enExample)
EP (1) EP1605918B1 (enExample)
JP (1) JP5072355B2 (enExample)
KR (1) KR20060012576A (enExample)
AU (1) AU2004224601A1 (enExample)
CA (1) CA2519962C (enExample)
FR (1) FR2852843B1 (enExample)
MX (1) MXPA05010217A (enExample)
NZ (1) NZ542590A (enExample)
WO (1) WO2004084856A2 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2852843B1 (fr) * 2003-03-24 2008-05-23 Karim Ioualalen Systeme galenique permettant le masquage du gout
FR2879930B1 (fr) * 2004-12-23 2007-08-31 Oralance Pharma Sa Nouveau systeme galenique pour le transport d'actif, procede de preparation et utilisation
FR2913884A1 (fr) * 2007-03-21 2008-09-26 Oralance Pharma Sa Systeme galenique hydrophobe non ionisable
US8613956B2 (en) * 2008-06-23 2013-12-24 International Flora Technologies, Ltd. Cosmetic particles that transform from hard to soft particles comprising hydrogenated long-chain triglyceride oils
FR2935270A1 (fr) * 2008-08-28 2010-03-05 Oralance Pharma Composition pharmaceutique de temozolomide pour usage pediatrique
CN104736229B (zh) * 2012-10-18 2017-05-03 帝斯曼知识产权资产管理有限公司 包含类胡萝卜素的珠粒
US20160000714A1 (en) 2013-03-06 2016-01-07 Capsugel Belgium Nv Curcumin solid lipid particles and methods for their preparation and use
EP3154529B1 (en) 2014-06-10 2020-07-08 Capsugel Belgium NV Orally disintegrating tablet containing solid lipid particles and methods for their preparation and use
US11324699B2 (en) 2014-12-04 2022-05-10 Capsugel Belgium Nv Lipid multiparticulate formulations
US9744221B2 (en) 2014-12-23 2017-08-29 Synthetic Biologics, Inc. Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
EP3551164B1 (fr) * 2016-12-08 2021-03-31 Salsarulo Pharma Médicament oral comprenant un laxatif osmotique incorporé dans une matrice à base de matières grasses végétales
FR3059903B1 (fr) * 2016-12-08 2019-03-22 Salsarulo Pharma Medicament oral comprenant un laxatif osmotique incorpore dans une matrice a base de matieres grasses vegetales
US10639607B2 (en) 2017-06-16 2020-05-05 Matralix Pte Ltd Systems and methods for preparing wax and lipid particles
CN111328284A (zh) 2017-08-07 2020-06-23 芬奇治疗公司 用于维持和恢复健康的肠道屏障的组合物和方法
US11338020B2 (en) 2018-01-09 2022-05-24 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of neurodevelopmental disorders
WO2019165285A1 (en) 2018-02-23 2019-08-29 Crestovo Holdings Llc Microbiome related immunotherapies
FR3078630B1 (fr) * 2018-03-08 2021-05-14 Karim Ioualalen Mode de formulation sous forme de solide divise hydrophobe
EP3773686B1 (en) 2018-03-20 2023-06-07 Theriva Biologics, Inc. Alkaline phosphatase agents for treatment of radiation disorders
ES3032290T3 (en) 2018-03-20 2025-07-16 Theriva Biologics Inc Intestinal alkaline phosphatase formulations
FR3079146B1 (fr) * 2018-03-23 2020-04-17 Karim Ioualalen Formulation gastroprotectrice de complexes d’enzymes permettant de restaurer la fonction digestive.
WO2021011754A1 (en) 2019-07-18 2021-01-21 Synthetic Biologics, Inc. Intestinal alkaline phosphatase-based treatments of metabolic disorders
WO2021016081A1 (en) 2019-07-19 2021-01-28 Finch Therapeutics Holdings Llc. Methods and products for treatment of gastrointestinal disorders
WO2021050965A1 (en) 2019-09-13 2021-03-18 Crestovo Holdings Llc Compositions and methods for treating autism spectrum disorder
AU2020366529A1 (en) 2019-10-18 2022-05-19 Finch Therapeutics Holdings Llc Compositions and methods for delivering a bacterial metabolite to a subject
WO2021097288A1 (en) 2019-11-15 2021-05-20 Finch Therapeutics Holdings Llc Compositions and methods for treating neurodegenerative diseases
WO2021142353A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for treating hepatitis b (hbv) and hepatitis d (hdv)
WO2021142358A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for treating hepatic encephalopathy (he)
WO2021142347A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for non-alcoholic steatohepatitis (nash)
US20230201265A1 (en) 2020-03-31 2023-06-29 Finch Therapeutics Holdings Llc Compositions comprising non-viable fecal microbiota and methods of use thereof
US20240263251A1 (en) 2021-02-19 2024-08-08 Finch Therapeutics Holdings Llc Compositions and methods for providing secondary bile acids to a subject
CN113308045B (zh) * 2021-05-28 2022-03-22 宁波市鑫晟工贸实业有限公司 一种抗老化的塑料盒及其制备方法
IT202100014330A1 (it) * 2021-06-01 2022-12-01 The Ubeauty Com Llc Prodotto per la cura della pelle e procedimento per la sua realizzazione.
US20230256056A1 (en) * 2022-02-11 2023-08-17 Insitu Biologics, Inc. Sustained release cancer therapeutics formulations

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
US4132753A (en) * 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
GB1323161A (en) * 1970-02-16 1973-07-11 Wyeth John & Brother Ltd Penicillin composition
US4132375A (en) * 1976-01-21 1979-01-02 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Vortex-lift roll-control device
US4590062A (en) * 1984-04-16 1986-05-20 Tech Trade Corp. Dry direct compression compositions for controlled release dosage forms
JPS63301815A (ja) * 1987-01-29 1988-12-08 Taisho Pharmaceut Co Ltd 経口製剤の製造方法
JP2700662B2 (ja) * 1988-06-22 1998-01-21 大正製薬株式会社 被覆製剤
JPH02200639A (ja) * 1989-01-31 1990-08-08 Shinfusou Seiyaku Kk 脂質被覆細菌製剤
IT1229856B (it) 1989-04-20 1991-09-13 Recordati Chem Pharm Compresse a rilascio controllato contenenti flavossato.
US5213810A (en) 1990-03-30 1993-05-25 American Cyanamid Company Stable compositions for parenteral administration and method of making same
ATE134873T1 (de) 1991-07-23 1996-03-15 American Cyanamid Co Stabile zusammensetzungen für parenterale verabrechung und ihre verwendung
DE4131562A1 (de) 1991-09-18 1993-03-25 Medac Klinische Spezialpraep Arzneistofftraeger aus festen lipidteilchen-feste lipidnanosphaeren (sln)
KR950703935A (ko) * 1992-11-30 1995-11-17 밋첼 아이, 커시너 맛을 차단하는 약제학적 조성물
CA2091152C (en) 1993-03-05 2005-05-03 Kirsten Westesen Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
DE4308282C2 (de) 1993-03-16 1994-12-22 Beiersdorf Ag Vorzugsweise in Form von Mikrosphärulen vorliegende galenische Matrices
JP2001524131A (ja) 1997-05-09 2001-11-27 セイジ、ファーマスーティカルズ、インク 安定な経口医薬品剤形
EP1028712B1 (en) 1997-09-19 2005-01-12 Shire Laboratories Inc. Solid solution beadlet
FR2769839B1 (fr) * 1997-10-21 1999-12-17 Odette Mercedes Salsarulo Composition anhydre a base de lactulose
FR2779962B1 (fr) * 1998-06-17 2002-12-06 Karim Ioualalen Composition cosmetique ou dermopharmaceutique sous forme de perles et procedes pour la preparation
WO2000067728A2 (de) 1999-05-07 2000-11-16 Pharmasol Gmbh Lipidpartikel auf der basis von mischungen von flüssigen und festen lipiden und verfahren zu ihrer herstellung
RU2246293C2 (ru) 1999-06-14 2005-02-20 Космо С.П.А. Фармацевтические композиции для перорального введения с регулируемым высвобождением активного ингредиента и маскируемым вкусом
ITMI991316A1 (it) 1999-06-14 2000-12-14 Cip Ninety Two 92 S A Composizioni farmaceutiche orali a rilascio modificato di mesalazina
DE60133706T2 (de) * 2000-10-10 2009-07-02 Wyeth Holdings Corp. Stabilisierte Arzneizusammensetzungen zur parenteralen Vearbreichung
JP3597823B2 (ja) 2002-02-07 2004-12-08 沢井製薬株式会社 固形製剤
FR2852843B1 (fr) 2003-03-24 2008-05-23 Karim Ioualalen Systeme galenique permettant le masquage du gout

Similar Documents

Publication Publication Date Title
JP2006521334A5 (enExample)
CN1055615C (zh) 增湿性唇膏组合物
EP0573978B1 (en) Bath additive composition comprising surfactant-containing seamless capsules and method for producing the capsules.
AU650683B2 (en) Melt granulating method for drug formulation
TW202034896A (zh) 含乙酸纖維素之粒子、化妝品組成物及含乙酸纖維素之粒子之製造方法
JPH0475054B2 (enExample)
PL191147B1 (pl) Sposób wytwarzania koncentratu środka zapachowego i wyrobu zawierającego ten koncentrat oraz wyrób zawierający koncentrat środka zapachowego, a zwłaszcza świeca z udziałem parafiny
JP2005520003A (ja) 有益物質粒子を含む秩序液晶性洗浄組成物
JPS60116627A (ja) 脈管内輸送用微小球の製法
CA1187795A (en) Method for preparing galenic formulations particularly for pharmaceutical, dietetical, cosmetic and diagnostic uses
HUE032736T2 (en) Feed additive preparation containing an acidic or neutral amino acid for ruminant animals, and a method for producing it
JP2020514044A (ja) 少なくとも1種の揮発性化合物を含むカプセルを製造する方法およびその方法から得られるカプセル
JP2002504425A (ja) ミクロ粒子又はナノ粒子製造用マトリックス、前記粒子の製造方法及び得られる粒子
JP4823675B2 (ja) ハイドロゲル粒子の製造方法、並びに、それによって製造されるハイドロゲル粒子及びそれを用いた分散体
JP2003055219A (ja) マイクロカプセル並びに錠剤、食品用及び医薬品用配合剤
JP7510250B2 (ja) 細塵除去用多孔性複合粉体及びその製造方法
JPH0279935A (ja) バター様スプレッド
JPS6084210A (ja) 固型粉末調合剤及びその製造方法
JP2019523317A (ja) 固形石鹸組成物
JP2002104958A (ja) 親油性ビタミン製剤
JPH0657290A (ja) チキソトロピーを有するゲル状組成物
JP2000086502A (ja) 徐放性マイクロスフエアの製造法
HRP20220965T1 (hr) Formulacija probavnog enzima za oslobađanje u crijevima, postupak proizvodnje i galenski pripravak
JP5926647B2 (ja) 代用乳及びその製造方法
JP3347579B2 (ja) ココア粉末の水濡れ性改良用油脂組成物